Qiagen NV
QGEN42.410USD
+0.339+0.81%
交易中 （美东）报价延迟15分钟
9.17B总市值
109.65市盈率 TTM
关于 Qiagen NV 公司
Qiagen NV 是一家总部位于荷兰的控股公司。该公司致力于提供从样本到洞察的解决方案，将生物样本转化为分子洞察。其从样本到洞察解决方案集成了样本和分析技术、生物信息学和自动化系统。其样本技术用于从血液或其他液体、组织、植物或其他材料中分离和制备脱氧核糖核酸 (DNA)、核糖核酸 (RNA) 和蛋白质。其分析技术使这些生物分子可见以供分析，例如识别病原体的遗传信息或肿瘤中的基因突变。其生物信息学解决方案解释数据以提供可操作的洞察。该公司基于聚合酶链反应 (PCR)、下一代测序 (NGS) 和其他技术的自动化平台将这些技术结合在一起，形成从样本到洞察的分子检测工作流程。
公司简介
公司代码QGEN
公司名称Qiagen NV
上市日期Sep 01, 1996
成立日期1996
CEOMr. Thierry Bernard
员工数量5765
证券类型Ordinary Share
年结日Sep 01
公司地址Hulsterweg 82
城市VENLO
上市交易所NYSE Consolidated
国家Netherlands
邮编5912 PL
电话31773556600
网址https://www.qiagen.com/
公司代码QGEN
上市日期Sep 01, 1996
成立日期1996
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Lawrence A. Rosen
Mr. Lawrence A. Rosen
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
业务USD
名称
营收
占比
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
地区USD
名称
营收
占比
United States
942.01M
47.62%
Europe & Middle East & Africa
648.49M
32.78%
Asia, Pacific & Rest of the World
298.15M
15.07%
Other Americas
89.56M
4.53%
业务
地区
业务USD
名称
营收
占比
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
股东统计
更新时间: 4月25日 周五
更新时间: 4月25日 周五
持股股东
股东类型
持股股东
股东统计
占比
Wellington Management Company, LLP
10.78%
BlackRock Institutional Trust Company, N.A.
8.94%
The Vanguard Group, Inc.
3.95%
Amundi Asset Management, SAS
2.18%
Nuance Investments, LLC
1.86%
Other
72.29%
持股股东
股东统计
占比
Wellington Management Company, LLP
10.78%
BlackRock Institutional Trust Company, N.A.
8.94%
The Vanguard Group, Inc.
3.95%
Amundi Asset Management, SAS
2.18%
Nuance Investments, LLC
1.86%
Other
72.29%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
28.53%
Investment Advisor
28.51%
Hedge Fund
2.60%
Sovereign Wealth Fund
1.88%
Holding Company
1.44%
Research Firm
1.42%
Pension Fund
0.90%
Bank and Trust
0.81%
Individual Investor
0.44%
Other
33.47%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
973
142.86M
66.10%
-56.12M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
2022Q4
1009
160.10M
74.55%
-10.38M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
23.29M
10.78%
+2.11M
+9.98%
Jan 31, 2025
BlackRock Institutional Trust Company, N.A.
19.32M
8.94%
-13.86K
-0.07%
Mar 04, 2025
The Vanguard Group, Inc.
8.54M
3.95%
+77.90K
+0.92%
Dec 31, 2024
Amundi Asset Management, SAS
4.71M
2.18%
-798.61K
-14.50%
Dec 31, 2024
Nuance Investments, LLC
4.03M
1.86%
-338.28K
-7.74%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
Bank of America Corp
3.95M
1.83%
+3.95M
--
May 10, 2024
BlackRock Asset Management Deutschland AG
2.75M
1.27%
+37.88K
+1.40%
Mar 31, 2025
Capital International Investors
2.36M
1.09%
--
--
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Global X Genomics & Biotechnology ETF
4.14%
Global X Telemedicine & Digital Health ETF
3.49%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.17%
Invesco Biotechnology & Genome ETF
2.41%
VanEck Biotech ETF
1.43%
Franklin Genomic Advancements ETF
1.41%
ROBO Global Healthcare Technology & Innovation ETF
1.37%
WisdomTree BioRevolution Fund
1.16%
iShares Health Innovation Active ETF
0.82%
FlexShares US Quality Low Volatility Index Fund
0.74%
查看更多
Global X Genomics & Biotechnology ETF
占比4.14%
Global X Telemedicine & Digital Health ETF
占比3.49%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比3.17%
Invesco Biotechnology & Genome ETF
占比2.41%
VanEck Biotech ETF
占比1.43%
Franklin Genomic Advancements ETF
占比1.41%
ROBO Global Healthcare Technology & Innovation ETF
占比1.37%
WisdomTree BioRevolution Fund
占比1.16%
iShares Health Innovation Active ETF
占比0.82%
FlexShares US Quality Low Volatility Index Fund
占比0.74%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
公告日期
类型
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25